Viewing Study NCT05623995


Ignite Creation Date: 2025-12-24 @ 1:12 PM
Ignite Modification Date: 2025-12-27 @ 10:40 PM
Study NCT ID: NCT05623995
Status: UNKNOWN
Last Update Posted: 2023-11-13
First Post: 2022-11-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Evolocumab on Chronic Total Occlusions (EVOLO-CTO)
Sponsor: Lin Zhao
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None In-stent Restenosis View
None Major Adverse Cardiovascular Events View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic total occlusion View
None Restenosis View